Sterile Pharmaceutical Manufacturing

The contract calls for the manufacture of 250 mL Sodium Chloride 0.9% Injection in full compliance with FDA current Good Manufacturing Practices and USP standards, ensuring the highest quality and sterility for pharmaceutical use. Production must also meet specific military packaging requirements, indicating the product is destined for defense or federal medical supply chains. The work is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and is being procured by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as Fort Bragg, North Carolina, with a response deadline of August 10, 2026, and the solicitation was posted on August 2, 2026, leaving a narrow window for interested parties to submit proposals. All manufacturing, quality control, and packaging processes must align with stringent federal and military guidelines to ensure compatibility with existing supply and distribution systems.